Italy: stem cell row spices up ATMP controls move
This article was originally published in Clinica
Italy has passed emergency legislation that controversially allows the continued use of an unapproved advanced therapy medicinal product (ATMP) technique while seeking to tighten controls in this area, including banning ATMP procedures in anything but state-controlled centres.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.
Our updated graphic tracker of key developments from the leading vaccine candidates.